StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –

Novartis Diovan Group Global Growth in USD by Quarter

Diovan Group Global Growth in USD (% USD) (%)

QuarterlyAnnual

Novartis Diovan Group Global Growth in USD: -4.0% in Q3 2026, up 1.0 pts from a year earlier.

Latest, Q3 2026
-4.0%
Period ended Sep 30, 2026
Change on a year earlier
+1.0 pts
-5.0% in Q3 2025
History
27 quarters
Since Q4 2018
Sources
27
Documents cited below

Where the Q3 2026 figure comes from

“|| Diovan Group | 137 | 143 | – 4 | – 6”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDiovan Group Global Growth in USD (% USD) (%)Year on yearSource
Q3 2026Sep 30, 2026-4.0%+1.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20264.0%+8.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20260.0%-7.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202512.0%+17.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025-5.0%-3.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 2025-4.0%-7.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 20257.0%+18.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 2024-5.0%-9.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 2024-2.0%+2.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 20243.0%+6.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 2024-11.0%+6.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 20234.0%+29.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 2023-4.0%+7.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 2023-3.0%–Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 2023-17.0%–Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 2022-25.0%–Novartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis Diovan Group Global Growth in USD (%), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-diovan-group-yoy-usd-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.